[144] Oscar Health, Inc. SEC Filing
OSCR filed a Form 144 notice for a proposed sale of common stock. The filing lists 105,300 shares to be sold with an aggregate market value of $1,585,133.55, through Morgan Stanley Smith Barney LLC, on or about 11/12/2025. The shares trade on the NYSE.
The securities to be sold were acquired on 11/12/2025 via an exercise of options under a registered plan, with payment in cash. Shares outstanding were 229,010,000 as of the figures provided. The filing also reports sales in the past three months by a named seller: 286,182 shares on 11/11/2025 for $4,369,512.63, and 395,000 shares on 09/22/2025 for $7,280,995.50.
Form 144 is a notice of proposed sale under Rule 144 and does not itself effect a sale; it discloses intent and relevant limits and timing.
- None.
- None.
Insights
Routine Rule 144 notice for insider share sales; informational, not a deal.
This filing states an intent to sell 105,300 OSCR common shares with an aggregate value of
Rule 144 volume and manner-of-sale conditions apply, and the filing aggregates recent sales for compliance. The table lists additional sales of 286,182 shares on
This is typically neutral for valuation. It signals potential secondary selling activity; impact depends on execution and overall trading liquidity.